These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7678872)

  • 1. Medical management of benign prostatic hyperplasia: a canine model comparing the in vivo efficacy of alpha-1 adrenergic antagonists in the prostate.
    Breslin D; Fields DW; Chou TC; Marion DN; Kane M; Vaughan ED; Felsen D
    J Urol; 1993 Feb; 149(2):395-9. PubMed ID: 7678872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of prazosin, terazosin and tamsulosin: functional and binding studies in isolated prostatic and vascular human tissues.
    Amadesi S; Varani K; Spisani L; Daniele C; Turini A; Agnello G; Zamboni P; Borea PA; Geppetti P
    Prostate; 2001 Jun; 47(4):231-8. PubMed ID: 11398170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative evaluation of the efficacy of using terazosin and tamsulosin in patients with benign prostatic hyperplasia].
    Lopatkin NA; Sivkov AV; Surikov VN; Egorov AA
    Urologiia; 2002; (5 Suppl):3-12. PubMed ID: 12518668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ; Guo YL; Gu FL
    J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia.
    Lepor H; Gup DI; Baumann M; Shapiro E
    Urology; 1988 Dec; 32(6 Suppl):21-6. PubMed ID: 2462301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.
    Kyprianou N; Chon J; Benning CM
    Prostate Suppl; 2000; 9():42-6. PubMed ID: 11056502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitative analyses of human prostatic alpha-adrenoceptors and effects of terazosin on the alpha-adrenoceptor activity].
    Morita T
    J Smooth Muscle Res; 1991 Jun; 27(3):149-54. PubMed ID: 1726720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-adrenergic mechanisms in dynamics of benign prostatic hypertrophy.
    Caine M
    Urology; 1988 Dec; 32(6 Suppl):16-20. PubMed ID: 2462300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro characterization of the alpha-adrenoceptors in human prostate.
    Hieble JP; Caine M; Zalaznik E
    Eur J Pharmacol; 1985 Jan; 107(2):111-7. PubMed ID: 2579826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alpha blockers in the treatment of benign hyperplasia of the prostate].
    Gómez Sancha F; Fernández Arjona M; Peinado Ibarra F; Fernández Borrell A; Mínguez Martínez R; Pereira Sanz I
    Rev Clin Esp; 1997 May; 197(5):358-62. PubMed ID: 9280971
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonist.
    Beduschi MC; Beduschi R; Oesterling JE
    Urology; 1998 Jun; 51(6):861-72. PubMed ID: 9609620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.
    Kenny BA; Naylor AM; Carter AJ; Read AM; Greengrass PM; Wyllie MG
    Urology; 1994 Jul; 44(1):52-7. PubMed ID: 7913781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of terazosin and tamsulosin for symptomatic benign prostatic hyperplasia in Japanese patients.
    Okada H; Kamidono S; Yoshioka T; Okuyama A; Ozono S; Hirao Y; Okajima E; Yamamoto K; Kishimoto T; Park Y; Kurita T
    BJU Int; 2000 Apr; 85(6):676-81. PubMed ID: 10759664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamsulosin: alpha1-adrenoceptor subtype-selectivity and comparison with terazosin.
    Muramatsu I; Taniguchi T; Okada K
    Jpn J Pharmacol; 1998 Nov; 78(3):331-5. PubMed ID: 9869267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.
    Kyprianou N
    J Urol; 2003 Apr; 169(4):1520-5. PubMed ID: 12629407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin.
    Seo KK; Lee MY; Lim SW; Kim SC
    J Korean Med Sci; 1999 Feb; 14(1):69-74. PubMed ID: 10102527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical therapy for benign prostatic hyperplasia: a review of the literature.
    Clifford GM; Farmer RD
    Eur Urol; 2000 Jul; 38(1):2-19. PubMed ID: 10859436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the alpha-adrenoceptor characteristics in human and canine prostate.
    Hieble JP; Boyce AJ; Caine M
    Fed Proc; 1986 Oct; 45(11):2609-14. PubMed ID: 2428671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: a short-term open, randomized multicenter study. BPH Medical Therapy Study Group. Benign prostatic hyperplasia.
    Tsujii T
    Int J Urol; 2000 Jun; 7(6):199-205. PubMed ID: 10843450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.